Prothrombin Time Testing: Principles, Methodology, Clinical Interpretation, and Quality Assurance in Hemostasis Laboratories

Mohammed Ibrahim Mohsen Gomer (1), Abdullah Essa Magbool Oraybi , Khalid Hamoud Najea Somaily , Ahlam Mohammed Ahmed Arishi , Essa Ali Ali Oraybi , Abdullah Zain Abdullah Abbas , Muteeb Mohamed Alasiri (2), Badr Amer Alhrbi (3), Samar Ahmad Breagesh (4), Khlood Abdu Ali Dagreery (5)
(1) Jazan Health Cluster,Ministry of Health, Saudi Arabia,
(2) King Salman Hospital  , Ministry of Health, Saudi Arabia,
(3) Imam Abdulrahman Al Faisal Hospital Laboratory,Ministry of Health, Saudi Arabia,
(4) Riyadh Regional Lab,Ministry of Health, Saudi Arabia,
(5) Jazan Regional Laboratory,Ministry of Health, Saudi Arabia

Abstract

Background: Prothrombin time (PT) is a critical coagulation assay widely used to assess the extrinsic and common pathways of hemostasis. It plays a pivotal role in monitoring anticoagulant therapy, evaluating bleeding risk, and diagnosing systemic disorders such as liver disease and disseminated intravascular coagulation.


Aim: This review aims to provide a comprehensive overview of PT testing, including its principles, methodology, clinical interpretation, and quality assurance practices in modern hemostasis laboratories.


Methods: The article synthesizes current evidence and best practices regarding PT assay performance, specimen collection, endpoint detection technologies, and quality control measures. It also examines preanalytical, analytical, and postanalytical factors influencing test reliability.


Results: PT testing has evolved from manual tilt-tube techniques to automated optical and mechanical detection systems, improving precision and scalability. The introduction of the International Normalized Ratio (INR) standardized reporting across laboratories, enhancing safety in anticoagulation management. Point-of-care (POC) devices have expanded access to rapid testing, though limitations persist in critically ill patients. Quality assurance, including internal QC, reagent lot verification, and external proficiency testing, remains essential to ensure accuracy.


Conclusion: PT/INR testing is indispensable for clinical decision-making, but its reliability depends on rigorous preanalytical control, method-aware interpretation, and adherence to quality standards. Technological advances and decentralized testing models offer convenience but require careful oversight to maintain patient safety.

Full text article

Generated from XML file

References

Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clinics in laboratory medicine. 2014 Sep:34(3):453-77. doi: 10.1016/j.cll.2014.06.005.

Triplett DA. Coagulation and bleeding disorders: review and update. Clinical chemistry. 2000 Aug:46(8 Pt 2):1260-9

van den Besselaar AM, Chantarangkul V, Tripodi A. Thromboplastin standards. Biologicals : journal of the International Association of Biological Standardization. 2010 Jul:38(4):430-6. doi: 10.1016/j.biologicals.2010.02.012.

Barcellona D, Fenu L, Marongiu F. Point-of-care testing INR: an overview. Clinical chemistry and laboratory medicine. 2017 May 1:55(6):800-805. doi: 10.1515/cclm-2016-0381.

Stein P, Kaserer A, Spahn GH, Spahn DR. Point-of-Care Coagulation Monitoring in Trauma Patients. Seminars in thrombosis and hemostasis. 2017 Jun:43(4):367-374. doi: 10.1055/s-0037-1598062.

Ebner M, Birschmann I, Peter A, Spencer C, Härtig F, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants. Critical care (London, England). 2017 Feb 15:21(1):32. doi: 10.1186/s13054-017-1619-z.

Bolliger D, Tanaka KA. Point-of-Care Coagulation Testing in Cardiac Surgery. Seminars in thrombosis and hemostasis. 2017 Jun:43(4):386-396. doi: 10.1055/s-0037-1599153.

Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thrombosis journal. 2016:14():49. doi: 10.1186/s12959-016-0123-z.

Hinds PS, Quargnenti A, Gattuso J, Kumar Srivastova D, Tong X, Penn L, West N, Cathey P, Hawkins D, Wilimas J, Starr M, Head D. Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer. Oncology nursing forum. 2002 Apr:29(3):E26-34

Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clinic proceedings. 2007 Jul:82(7):864-73

Winter WE, Flax SD, Harris NS. Coagulation Testing in the Core Laboratory. Laboratory medicine. 2017 Nov 8:48(4):295-313. doi: 10.1093/labmed/lmx050.

Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Seminars in thrombosis and hemostasis. 2013 Apr:39(3):258-66. doi: 10.1055/s-0032-1328972.

Opartkiattikul N. Standardization of coagulation tests. The Southeast Asian journal of tropical medicine and public health. 1999:30 Suppl 3():79-85

Kagawa K. [Prothrombin time and its standardization]. Rinsho byori. The Japanese journal of clinical pathology. 2002 Aug:50(8):779-85

Scherer-Burić RA, Lesser-Wetzold K, Nagel D, Weigand M, Spannagl M, Teupser D, Bruegel M. Performance testing of four automated coagulation analyzers in a university hospital setting with focus on global coagulation assays. International journal of laboratory hematology. 2022 Jun:44(3):643-653. doi: 10.1111/ijlh.13814.

Lim HY, Donnan G, Nandurkar H, Ho P. Global coagulation assays in hypercoagulable states. Journal of thrombosis and thrombolysis. 2022 Jul:54(1):132-144. doi: 10.1007/s11239-021-02621-1.

Huber AR, Méndez A, Brunner-Agten S. Automation in haemostasis. Hamostaseologie. 2013:33(4):295-8. doi: 10.5482/HAMO-12-05-0002.

Aggarwal S, Nayak DM, Manohar C. Discrepancy in optical & mechanical method in coagulation tests in a turbid sample. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2014 Sep:30(Suppl 1):402-4. doi: 10.1007/s12288-014-0438-5.

Tekkesin N, Kılınc C. Optical and mechanical clot detection methodologies: a comparison study for routine coagulation testing. Journal of clinical laboratory analysis. 2012 May:26(3):125-9. doi: 10.1002/jcla.21497.

Bai B, Christie DJ, Gorman RT, Wu JR. Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2008 Sep:19(6):569-76. doi: 10.1097/MBC.0b013e3283070872.

Walenga JM, Fareed J. Automation and quality control in the coagulation laboratory. Clinics in laboratory medicine. 1994 Dec:14(4):709-28

Hertzberg MS, Mammen J, McCraw A, Nair SC, Srivastava A. Achieving and maintaining quality in the laboratory. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Jul:12 Suppl 3():61-7

Ruiz-de-Chávez-Ochoa AA, Núñez-Pérez E, Muñoz-Muñoz B, Majluf-Cruz A. [The quality control in the coagulation laboratory]. Revista medica del Instituto Mexicano del Seguro Social. 2008 May-Jun:46(3):339-48

McFarlane A, Aslan B, Raby A, Moffat KA, Selby R, Padmore R. Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns-of-practice survey. International journal of laboratory hematology. 2015 Dec:37(6):729-38. doi: 10.1111/ijlh.12397.

Lu Y, Yang F, Wen D, Shi K, Gu Z, Lu Q, Wang X, Dong D. Assessment of patient based real-time quality control on comparative assays for common clinical analytes. Journal of clinical laboratory analysis. 2022 Sep:36(9):e24651. doi: 10.1002/jcla.24651.

Loh TP, Bietenbeck A, Cervinski MA, van Rossum HH, Katayev A, Badrick T, International Federation of Clinical Chemistry and Laboratory Medicine Committee on Analytical Quality. Recommendation for performance verification of patient-based real-time quality control. Clinical chemistry and laboratory medicine. 2020 Jul 28:58(8):1205-1213. doi: 10.1515/cclm-2019-1024.

Kinns H, Pitkin S, Housley D, Freedman DB. Internal quality control: best practice. Journal of clinical pathology. 2013 Dec:66(12):1027-32. doi: 10.1136/jclinpath-2013-201661.

Westgard JO. Internal quality control: planning and implementation strategies. Annals of clinical biochemistry. 2003 Nov:40(Pt 6):593-611

Mrazek C, Lippi G, Keppel MH, Felder TK, Oberkofler H, Haschke-Becher E, Cadamuro J. Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions. Biochemia medica. 2020 Jun 15:30(2):020502. doi: 10.11613/BM.2020.020502.

Ricós C, García-Victoria M, de la Fuente B. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management. Clinical chemistry and laboratory medicine. 2004:42(6):578-82

Badrick T. Integrating quality control and external quality assurance. Clinical biochemistry. 2021 Sep:95():15-27. doi: 10.1016/j.clinbiochem.2021.05.003.

Smock KJ, Moser KA. What have we learned from coagulation laboratory participation in external quality programs? International journal of laboratory hematology. 2019 May:41 Suppl 1():49-55. doi: 10.1111/ijlh.12998.

De la Salle B. Survey material choices in haematology EQA: a confounding factor in automated counting performance assessment. Biochemia medica. 2017 Feb 15:27(1):63-72. doi: 10.11613/BM.2017.008.

Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica. 1999 Dec:84(12):1065-74

Kremers RMW, Zuily S, Kelchtermans H, Peters TC, Bloemen S, Regnault V, Hemker HC, de Groot PG, Wahl D, de Laat B. Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin. Blood advances. 2018 Jun 12:2(11):1315-1324. doi: 10.1182/bloodadvances.2018018036.

Hanslik T, Prinseau J. The use of vitamin K in patients on anticoagulant therapy: a practical guide. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2004:4(1):43-55

Martinuzzo M, Barrera L, Rodriguez M, D'Adamo MA, López MS, Otaso JC. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients? International journal of laboratory hematology. 2015 Dec:37(6):853-60. doi: 10.1111/ijlh.12424. Epu

Gosselin RC, Marlar RA. Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results. Seminars in thrombosis and hemostasis. 2019 Jul:45(5):433-448. doi: 10.1055/s-0039-1692700.

Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods in molecular biology (Clifton, N.J.). 2017:1646():29-42. doi: 10.1007/978-1-4939-7196-1_2.

Adcock Funk DM, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation, and storage in hemostasis testing. Seminars in thrombosis and hemostasis. 2012 Sep:38(6):576-85. doi: 10.1055/s-0032-1319768.

Haripersadh R, Pillay D, Rapiti N. Impact of rapid centrifugation on routine coagulation assays in South Africa. African journal of laboratory medicine. 2022:11(1):1901. doi: 10.4102/ajlm.v11i1.1901.

Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effect of Multiple Freeze-Thaw Cycles on Coagulation Testing. Seminars in thrombosis and hemostasis. 2020 Jun:46(4):515-520. doi: 10.1055/s-0040-1709474.

Hellenbart EL, Faulkenberg KD, Finks SW. Evaluation of bleeding in patients receiving direct oral anticoagulants. Vascular health and risk management. 2017:13():325-342. doi: 10.2147/VHRM.S121661.

Kim JA, Kim JE, Song SH, Kim HK. Influence of blood lipids on global coagulation test results. Annals of laboratory medicine. 2015 Jan:35(1):15-21. doi: 10.3343/alm.2015.35.1.15.

Authors

Mohammed Ibrahim Mohsen Gomer
mgomer@moh.gov.sa (Primary Contact)
Abdullah Essa Magbool Oraybi
Khalid Hamoud Najea Somaily
Ahlam Mohammed Ahmed Arishi
Essa Ali Ali Oraybi
Abdullah Zain Abdullah Abbas
Muteeb Mohamed Alasiri
Badr Amer Alhrbi
Samar Ahmad Breagesh
Khlood Abdu Ali Dagreery
Gomer, M. I. M., Abdullah Essa Magbool Oraybi, Khalid Hamoud Najea Somaily, Ahlam Mohammed Ahmed Arishi, Essa Ali Ali Oraybi, Abdullah Zain Abdullah Abbas, … Khlood Abdu Ali Dagreery. (2025). Prothrombin Time Testing: Principles, Methodology, Clinical Interpretation, and Quality Assurance in Hemostasis Laboratories. Saudi Journal of Medicine and Public Health, 2(2), 2703–2716. https://doi.org/10.64483/202522454

Article Details

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)